文献速递前列腺增生与排尿功能障碍

双极经尿道前列腺汽化术与绿激光选择性汽化术治疗小至中度良性前列腺梗阻的随机试验:2年结果

A randomized trial comparing bipolar transurethral vaporization of the prostate with GreenLight laser (xps-180watt) photoselective vaporization of the prostate for treatment of small to moderate benign prostatic obstruction: outcomes after 2 years.
PubMed 文献 · BJU Int · 2019-11-12

这项随机试验比较了双极经尿道前列腺汽化术(TUVP)与绿激光前列腺选择性汽化术(GL-PVP)治疗前列腺体积30-80 mL的良性前列腺梗阻患者。主要终点为24个月时国际前列腺症状评分(IPSS)的非劣效性。结果显示双极TUVP在症状控制方面不劣于GL-PVP,且成本更低,但需要长期随访耐久性。

要点

  • 双极TUVP在2年症状控制上不劣于GL-PVP。
  • GL-PVP成本显著高于双极TUVP。
  • 两组再治疗率无显著差异。

核心结论

  • 双极TUVP在2年症状控制方面不劣于GL-PVP,且成本更低,但耐久性需长期追踪。

研究设计与样本

  • 随机对照试验,纳入前列腺体积30-80 mL的患者,GL-PVP组58例,双极TUVP组61例。

主要发现

  • 1年和2年IPSS均值:GL-PVP组分别为7.1±3和7.9±2.9,双极TUVP组分别为6.3±3.1和7.2±2.8(P=0.8和P=0.31)。
  • 24个月IPSS平均差异为0.7(95%CI -0.6至2.3;P=0.6)。
  • 术后PSA下降中位数(范围):GL-PVP组1年和2年分别为64.7(25-99)%和65.9(50-99)%(P=0.006);双极TUVP组分别为32.1(28.6-89.7)%和39.3(68.8-90.5)%(P=0.005)。
  • 2年时因复发性膀胱出口梗阻再治疗:GL-PVP组8例(13.8%),双极TUVP组10例(16.4%)(P=0.8)。
  • 24个月时双极TUVP平均估计成本显著低于GL-PVP(P=0.01)。

临床怎么用

  • 对于前列腺体积30-80 mL的良性前列腺梗阻患者,双极TUVP可作为GL-PVP的非劣效替代方案,且成本更低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To test the non-inferiority of bipolar transurethral vaporization of the prostate (TUVP) compared to GreenLight laser (GL) photoselective vaporization of the prostate (PVP) for reduction of benign prostatic hyperplasia-related lower urinary tract symptoms in a randomized trial. METHODS: Eligible patients with prostate volumes of 30-80 mL were randomly allocated to GL-PVP (n = 58) or bipolar TUVP (n = 61). Non-inferiority of symptom score (International Prostate Symptom Score [IPSS]) at 24 months was evaluated. All peri-operative variables were recorded and compared. Urinary (IPSS, maximum urinary flow rate and post-void residual urine volume) and sexual (International Index of Erectile Function-15) outcome measures were evaluated at 1, 4, 12 and 24 months. Need for retreatment and complications, change in PSA level and health resources-related costs of both procedures were recorded and compared. RESULTS: Baseline and peri-operative variables were similar in the two groups. At 1, 4, 12 and 24 months, 117, 116, 99 and 96 patients, respectively, were evaluable. Regarding urinary outcome measures, there was no significant difference between the groups. The mean ± sd IPSS at 1 and 2 years was 7.1 ± 3 and 7.9 ± 2.9 (P = 0.8), respectively, after GL-PVP and 6.3 ± 3.1 and 7.2 ± 2.8, respectively, after bipolar TUVP (P = 0.31). At 24 months, the mean difference in IPSS was 0.7 (95% confidence interval -0.6 to 2.3; P = 0.6). The median (range) postoperative PSA reduction was 64.7 (25-99)% and 65.9 (50-99)% (P = 0.006) after GL-PVP, and 32.1 (28.6-89.7)% and 39.3 (68.8-90.5)% (P = 0.005) after bipolar TUVP, at 1 and 2 years, respectively. After 2 years, retreatment for recurrent bladder outlet obstruction was reported in eight (13.8%) and 10 (16.4%) patients in the GL-PVP and bipolar TUVP groups, respectively (P = 0.8). The mean estimated cost per bipolar TUVP procedure was significantly lower than per GL-PVP procedure after 24 months (P = 0.01). CONCLUSIONS: In terms of symptom control, bipolar TUVP was not inferior to GL-PVP at 2 years. Durability of the outcome needs to be tracked. The greater cost of GL-PVP compared with bipolar TUVP is an important concern.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Ghobrial FK, Shoma A, Elshal AM, et al. A randomized trial comparing bipolar transurethral vaporization of the prostate with GreenLight laser (xps-180watt) photoselective vaporization of the prostate for treatment of small to moderate benign prostatic obstruction: outcomes after 2 years. BJU Int. 2019. PMID: 31621175. doi:10.1111/bju.14926

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。